Filing Flows › HCA Healthcare (HCA) › Guidance history
HCA Healthcare (HCA) guidance history: what it guided and what it reported
HCA Healthcare gave guidance in 10 earnings releases on file since Jan 30, 2024. Of 2 guided periods since reported, it met or beat its own guidance twice (100%). Revenue: 2 of 2, on average +1.6% against the guided midpoint. Its releases raised guidance 3 times and lowered it 0 times.
Revenue
Met or beat 2 of 2 periods (1 above, 1 within, 0 below).
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $76.5B–$80.0B (Jan 27, 2026) → reaffirmed $76.5B–$80.0B (Jul 14, 2026) → reaffirmed $76.5B–$80.0B (Jul 24, 2026) | — | to be reported | — |
| FY2025 | $72.8B–$75.8B (Jan 24, 2025) → reaffirmed $72.8B–$75.8B (Jul 25, 2025) → raised $74.0B–$76.0B (Oct 24, 2025) | $75.6B | within the range | +0.8% |
| FY2024 | $67.8B–$70.2B (Jan 30, 2024) → reaffirmed $67.8B–$70.2B (Jul 23, 2024) | $70.6B | above the range | +2.3% |
Net income
This line is not in the statements Filing Flows reads, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $6.5B–$7.0B (Jan 27, 2026) → reaffirmed $6.5B–$7.0B (Jul 14, 2026) → reaffirmed $6.5B–$7.0B (Jul 24, 2026) | — | to be reported | — |
| FY2025 | $5.8B–$6.3B (Jan 24, 2025) → reaffirmed $5.8B–$6.3B (Jul 25, 2025) → raised $6.1B–$6.5B (Oct 24, 2025) | — | — | — |
| FY2024 | $5.2B–$5.6B (Jan 30, 2024) → reaffirmed $5.2B–$5.6B (Jul 23, 2024) | — | — | — |
EBITDA
This line is not in the statements Filing Flows reads, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $15.6B–$16.4B (Jan 27, 2026) → reaffirmed $15.6B–$16.4B (Jul 14, 2026) → reaffirmed $15.6B–$16.4B (Jul 24, 2026) | — | to be reported | — |
| FY2025 | $14.3B–$15.1B (Jan 24, 2025) → reaffirmed $14.3B–$15.1B (Jul 25, 2025) → raised $14.7B–$15.3B (Oct 24, 2025) | — | — | — |
| FY2024 | $12.8B–$13.6B (Jan 30, 2024) | — | — | — |
EPS
This line is not in the statements Filing Flows reads, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2024 | $19.70–$21.20 (Jul 23, 2024) | — | — | — |
Capital expenditures
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $5.0B–$5.5B (Jul 14, 2026) → reaffirmed $5.0B–$5.5B (Jul 24, 2026) | — | to be reported | — |
Adjusted EBITDA
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2024 | $12.8B–$13.6B (Jul 23, 2024) | — | — | — |
The latest quarter
HCA Healthcare, Q3 2026: revenue $19.8B (+4% year over year), operating margin 11.9%, net earnings $1.6B, operating cash flow $4.5B. The chart follows the revenue to costs, profit and cash.
Questions
Does HCA Healthcare beat its guidance?
HCA Healthcare gave guidance in 10 earnings releases on file since Jan 30, 2024. Of 2 guided periods since reported, it met or beat its own guidance twice (100%). Revenue: 2 of 2, on average +1.6% against the guided midpoint.
How often does HCA Healthcare raise guidance?
Its earnings releases raised guidance 3 times and lowered it 0 times since Jan 30, 2024.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.